Highlights and Quick Summary
- Long-Term Investments for the quarter ending June 30, 2023 was $2.32 Million (a 0.09% increase compared to previous quarter)
- Year-over-year quarterly Long-Term Investments increased by 0.26%
- Annual Long-Term Investments for 2022 was $2.32 Million (a 0.35% increase from previous year)
- Annual Long-Term Investments for 2021 was $2.31 Million (a 0.43% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-Term Investments of Dyne Therapeutics, Inc.
Most recent Long-Term Investmentsof DYN including historical data for past 10 years.Interactive Chart of Long-Term Investments of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Long-Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $2.32 | $2.32 | – | – | – |
2022 | $2.32 | $2.32 | $2.32 | $2.31 | $2.32 |
2021 | $2.31 | $2.31 | $2.89 | $2.3 | $2.31 |
2020 | $2.3 | – | – | – | $2.3 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology